Page last updated: 2024-10-21

4-(2-aminoethyl)benzenesulfonylfluoride and Multiple Myeloma

4-(2-aminoethyl)benzenesulfonylfluoride has been researched along with Multiple Myeloma in 1 studies

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Magill, L1
Lynas, J1
Morris, TC1
Walker, B1
Irvine, AE1

Other Studies

1 other study available for 4-(2-aminoethyl)benzenesulfonylfluoride and Multiple Myeloma

ArticleYear
Proteasome proteolytic activity in hematopoietic cells from patients with chronic myeloid leukemia and multiple myeloma.
    Haematologica, 2004, Volume: 89, Issue:12

    Topics: Apoptosis; Bone Marrow Cells; Cell Line, Tumor; Edetic Acid; Fusion Proteins, bcr-abl; Hematopoietic

2004